ARCHIVES

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

This article is from The Cancer Letter archive.

Vol. 24 No. 22 | June 5, 1998

Download PDF Visit The Full Archive

Related Articles

NCI Division Directors Seek Litton Phaseout, NIH Takeover At Frederick

October 27, 1978

In Brief: Healy Names President, CEO of Red Cross; AMA Supports annual Mammograms for 40+

July 16, 1999

ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote

June 27, 2014

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

NCI Buys Building For PDQ, ICRDB With Donated Money

December 10, 1982

DCE Board Delays Decision On New Collaborative Groups In Chemoprevention

November 30, 1984